Stock Screener ETF Screener

Penny Stock Screener Technical Analysis Screener

Dividend Center Best Dividend Stocks

Best High Yield Dividend Stocks Dividend Aristocrats Dividend Stock Comparison

Dividend Calculator Dividend Returns Comparison Dividend Calendar

My Experts Top Analysts Top Financial Bloggers Top-Performing Corporate Insiders Top Hedge Fund Managers Top Research Firms Top Individual Investors

Education

Personal Finance How To Use TipRanks TipRanks Labs Webinar Center Glossary FAQs

About Us

About TipRanks Contact Us Careers Reviews Mobile APP

Working with TipRanks

Enterprise Solutions Advertise with Us Top Online Brokers Become an Affiliate TipRanks News Wire Arrived EquityMultiple

Follow Us

TOOLS

Top Insiders Stocks

Notification Center

Top Smart Score Stocks

Plans & Pricing

Research Tools

Trending Stocks

Most Visited Websites

Daily Feeds

Daily Analyst Ratings

Daily Insider Trading Tracker

Calendars

Earnings Calendar

Dividend Calendar

Economic Calendar

Market Holidays

Economic Indicators

Economic Indicators Center

Unemployment Rate

Federal Funds Rate

Class Actions

Calculators

Dividend Calculator

Dividend Yield Calculator

Options Profit Calculator

Dollar Cost Averaging

Penny Stock Screener

Technical Analysis Screener

Dividend Center

Best Dividend Stocks

Best High Yield Dividend Stocks

Dividend Aristocrats

Dividend Stock Comparison

Dividend Calculator

Dividend Returns Comparison

Dividend Calendar

Top Financial Bloggers

Top-Performing Corporate Insiders

Top Hedge Fund Managers

Top Research Firms

Top Individual Investors

Personal Finance Center

Investing & Retirement

Spending & Savings

Calculators

Compound Interest Calculator

Mortgage Calculator

Auto Loan Calculator

Student Loan Calculator

401k Retirement Calculator

Enterprise Solutions

Education

How To Use TipRanks

About Us

Working with TipRanks

Enterprise Solutions

Top Online Brokers

Become an Affiliate

TipRanks News Wire

Follow Us

Corvus Pharmaceuticals Inc (CRVS)

NASDAQ:CRVS

US Market

CRVS

Corvus Pharmaceuticals

Analyst Forecasts

Technical Analysis

RESEARCH TOOLS

Top Analyst Stocks

Top Smart Score Stocks

reports

Corvus Pharmaceuticals (CRVS) Stock News & Sentiment

576 Followers

Corvus Pharmaceuticals Reports Promising Interim Data on Soquelitinib

Company Announcements

Corvus Pharmaceuticals Reports Promising Interim Data on Soquelitinib

1M ago

Corvus Pharmaceuticals Reports Promising Phase 1 Data and Financial Boost

Company Announcements

Corvus Pharmaceuticals Reports Promising Phase 1 Data and Financial Boost

2M ago

Corvus Pharmaceuticals Reports Q3 2024 Financial Results

Company Announcements

Corvus Pharmaceuticals Reports Q3 2024 Financial Results

3M ago

Is CRVS a Buy, Before Earnings?

Pre-Earnings

Is CRVS a Buy, Before Earnings?

4M ago

CRVS Earnings Report this Week: Is It a Buy, Ahead of Earnings?

Pre-Earnings

CRVS Earnings Report this Week: Is It a Buy, Ahead of Earnings?

7M ago

CRVS Earnings Report this Week: Is It a Buy, Ahead of Earnings?

Pre-Earnings

CRVS Earnings Report this Week: Is It a Buy, Ahead of Earnings?

10M ago

Corvus Pharmaceuticals: Insider Ownership Raises Power Concentration Concerns

Company Announcements

Corvus Pharmaceuticals: Insider Ownership Raises Power Concentration Concerns

11M ago

More CRVS News >

CRVS News on the Web

2025-02-04

Corvus Pharmaceuticals to Present at the Oppenheimer 35th Annual Healthcare Life Sciences Conference

Yahoo Finance

Neutral

2024-12-19

Corvus selloff on atopic dermatitis data 'way overdone,' says Mizuho

The Fly

Neutral

2024-12-18

Tessera gets sickle cell funding; Corvus shares slide on eczema data

BioPharma Dive

Neutral

2024-11-15

Corvus (CRVS) is on the Move, Here's Why the Trend Could be Sustainable

Zacks

Bullish

2024-11-11

Corvus Unveils Data On Ciforadenant's Potential To Overcome Immunotherapy Resistance In MCRPC

rttnews

Neutral

2024-10-17

Insiders of Corvus Pharmaceuticals Getting Good Value On Their US$1.03m Investment

Yahoo Finance

Neutral

2024-09-11

Corvus Stock Up on Initiation of Phase III Lymphoma Study on Lead Drug

Yahoo Finance

Neutral

2024-09-10

Corvus Pharmaceuticals Initiates Registrational Phase 3 Clinical Trial of Soquelitinib for Patients with Relapsed/Refractory Peripheral T-Cell Lymphoma

Yahoo Finance

Neutral

News Score - Last 7 Days

Neutral

CRVS

Sector Average

Media Buzz

This Week0 articles

Weekly Average0 articles

News Sentiment

This Week50%

Sector Average57%

See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is CRVS’s Media Buzz Sentiment?

Currently, no data Available

What is CRVS’s weekly average amount of articles?

Currently, no data Available

What is CRVS’s News Sentiment?

50% of articles about CRVS were positive this week, compared to its sector average of 57%.

Healthcare Stocks that are Trending in the News

SHGSingular Health Group Ltd

RCUSArcus Biosciences

HCMHUTCHMED

PENPenumbra

AMNAMN Healthcare Services

Showing the stocks with the most bullish news sentiment over the past week

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing